SoftBank to Spin Off Telecom Unit in $21 Billion IPO
*By Carlo Versano*
SoftBank Group, the Japanese multinational conglomerate with stakes in some of the hottest U.S. tech start-ups, is planning a massive IPO for its telecom arm that could become Japan's largest public offering to date, [Bloomberg](https://www.bloomberg.com/news/articles/2018-11-12/softbank-unveils-21-billion-ipo-of-mobile-business?srnd=premium) reported Monday.
SoftBank Founder Masayoshi Son is reportedly seeking $21 billion for the new entity that will be called SoftBank Corp. and begin trading Dec. 19. Citing the prospectus, Bloomberg said the company will offer 1.6 billion shares at 1,500 yen a piece, or roughly $13. That figure could change as the range of the offering is set.
Son has used his $100 billion Vision Fund to transform SoftBank into a holding company with stakes in some of the world's most valuable technology companies, including Uber, WeWork, and Alibaba ($BABA). Softbank's telecom and mobile operation has long been the company's bread and butter, and spinning it off will give Son room to further position himself as a tech kingmaker.
Nugget ice is booming across America. Middleby CEO Tim FitzGerald explains the craze, restaurant demand and why the trend could become a major growth engine.
Wearable robotics are moving beyond sci-fi. Dephy CEO Luke Mooney explains how its smart ankle exoskeleton is changing mobility, recovery and everyday movement.
Voice AI is moving into cars, restaurants and customer service. SoundHound CEO Keyvan Mohajer explains the company’s growth and the future of voice-powered AI.
Americans are still spending, but rising anxiety over jobs, AI, housing and tariffs tells a different story. Kearney Consumer Institute’s Katie Thomas explains.
Disney is back in focus after Q3 earnings. Investors are watching streaming profits, theme parks and ESPN as the entertainment giant looks for its next catalyst
Healthcare policy is shifting fast, raising questions about drug prices, Medicare and access. Leap Health CEO Hani Elias explains what patients need to know.
